Clinical Trials Logo

Poor Graft Function clinical trials

View clinical trials related to Poor Graft Function.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT03718533 Terminated - Poor Graft Function Clinical Trials

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

ELTION
Start date: December 17, 2018
Phase: Phase 2
Study type: Interventional

The purpose of this study was to evaluate the efficacy of eltrombopag for poor graft function (PGF) on overall hematologic response (partial and complete), as determined by platelet, hemoglobin and neutrophil counts by 16 weeks after the initiation of eltrombopag in patients with poor graft function after allogeneic hematopoietic stem cell transplantation (allo-HSCT).